UK ‘animal research’ labelling plan may have unintended consequences says Cyprotex
Proposed UK “animal research” labelling laws may backfire if improvements in culture-based toxicology testing continue, according to in vitro CRO Cyprotex.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs